Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...
LONDON & NEW YORK, January 06, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today ...
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering ...
It's been a long road for Compass Pathways (NASDAQ: CMPS) to prove that its treatment using psilocybin therapy for treatment-resistant depression (TRD) can be successful. It was back in 2018 when the ...
COMPASS Pathways plc (NASDAQ:CMPS) is given fourth position on our list of most promising stocks. TheFly reported on February 14 that LifeSci Capital was bullish on CMPS, as the firm initiated ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する